Approach to the patient with suspectedmyasthenia gravis or als: A clinician's guide

CONTINUUM Lifelong Learning in Neurology

Volumn 15, Issue 1, 2009, Pages 13-34

  Rowin, Julie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PYRIDOSTIGMINE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BABINSKI REFLEX; BREATHING MUSCLE; BULBAR PARALYSIS; COGNITIVE DEFECT; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DYSARTHRIA; DYSPHAGIA; ELECTRODIAGNOSIS; ELECTROMYOGRAM; EXTRAOCULAR MUSCLE; FASCICULATION; HUMAN; HYPERREFLEXIA; HYPOREFLEXIA; LIMB WEAKNESS; MOTONEURON; MUSCLE ATROPHY; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; SPASTICITY; TONGUE DISEASE; WEIGHT REDUCTION;

EID: 78650753974     PISSN: 10802371     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.CON.0000300006.49351.2c     Document Type: Article

References (18)

1. Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1(5):293-299.
2. Casasnovas C, Povedano M, Jauma S, et al. Musk-antibody positive myasthenia gravis presenting with isolated neck extensor weakness. Neuromuscul Disord 2007; 17(7):544-546.
3. Colton-Hudson A, Koopman R, Moosa T, et al. A prospective assessment of the characteristics of dysphagia in myasthenia gravis. Dysphagia 2002;17(2):147-151.
4. D'Amelio M, Di Benedetto N, Ragonese P, et al. Dropped head as an unusual presenting sign of myasthenia gravis. Neurol Sci 2007;28(2):104-106.
5. de Carvalho M, Dengler R, Eisen A, et al. Electrodiagnostic criteria for the diagnosis of ALS. Clin Neurophysiol 2008;119(3):497-503.
6. Desport JC, Torny F, Lacoste M, et al. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegenerative Dis 2005;2(3-4):202-207.
7. Gorelick PB, Rosenberg M, Pagano RJ. Enhanced ptosis in myasthenia gravis. Arch Neurol 1981;38(8):531.
8. Grob D. Course and management of myasthenia gravis. JAMA 1953;153(6):529-532.
9. Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve 2008;37(2):141-149.
10. Hammad M, Silva A, Glass J, et al. Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS. Neurology 2007;69(24):2236-2242.
11. Jani-Ascadi A, Lisak RP. Myasthenia crisis: guidelines for prevention and treatment. J Neurol Sci 2007;261(1-2):127-133.
12. Larner AJ. The place of the ice pack test in the diagnosis of myasthenia gravis. Int J Clin Pract 2004;58(9):887-888.
13. Llabres M, Molina-Martiex FJ, Miralles F. Dysphagia as the sole manifestation of myasthenia gravis. J Neurol Neurosurg Psychiatry 2005;76(9):1297-1300.
14. Lomen-Hoerth C. Characterization of amyotrophic lateral sclerosis and frontotemporal dementia. Dement Geriatr Cogn Disord 2004;17(4):337-341.
15. Murphy JM, Henry RG, Langmore S, et al. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol 2007;64(4):530-534.
16. Nations SP, Wolfe GI, Amato AA, et al. Distal myasthenia gravis. Neurology 1999;52(3): 632-634.
17. Traynor BJ, Codd MB, Corr B, et al. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria. Arch Neurol 2000;57: 1171-1176.
18. Vucic S, Krishnan AV, Kiernan MC. Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2007;78(11): 1202-1208.